Press "Enter" to skip to content

New patent expiration for Clovis Oncology drug RUBRACA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Clovis Oncology drug RUBRACA

Annual Drug Patent Expirations for RUBRACA
Annual Drug Patent Expirations for RUBRACA

Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

This drug has two hundred and forty-three patent family members in fifty-three countries.

The generic ingredient in RUBRACA is rucaparib camsylate. One supplier is listed for this compound. Additional details are available on the rucaparib camsylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Clovis Oncology drug RUBRACA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!